A new measure of classifier performance for gene expression data.

IEEE/ACM Trans Comput Biol Bioinform

LIPADE, University Paris Descartes, Paris, France.

Published: January 2013

One of the major aims of many microarray experiments is to build discriminatory diagnosis and prognosis models. A large number of supervised methods have been proposed in literature for microarray-based classification for this purpose. Model evaluation and comparison is a critical issue and, the most of the time, is based on the classification cost. This classification cost is based on the costs of false positives and false negative, that are generally unknown in diagnostics problems. This uncertainty may highly impact the evaluation and comparison of the classifiers. We propose a new measure of classifier performance that takes account of the uncertainty of the error. We represent the available knowledge about the costs by a distribution function defined on the ratio of the costs. The performance of a classifier is therefore computed over the set of all possible costs weighted by their probability distribution. Our method is tested on both artificial and real microarray data sets. We show that the performance of classifiers is very depending of the ratio of the classification costs. In many cases, the best classifier can be identified by our new measure whereas the classic error measures fail.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TCBB.2012.21DOI Listing

Publication Analysis

Top Keywords

measure classifier
8
classifier performance
8
evaluation comparison
8
classification cost
8
costs
5
performance
4
performance gene
4
gene expression
4
expression data
4
data major
4

Similar Publications

Background: A mobile cognition scale for community screening in cognitive impairment with rigorous validation is in paucity. We aimed to develop a digital scale that overcame low education for community screening for mild cognitive impairment (MCI) due to Alzheimer's disease (AD) and AD.

Methods: A mobile cognitive self-assessment scale (CogSAS) was designed through the Delphi process, which is feasible for the older population with low education.

View Article and Find Full Text PDF

Predicting early diagnosis of intensive care unit-acquired weakness in septic patients using critical ultrasound and biological markers.

BMC Anesthesiol

January 2025

Department of Critical Care Medicine, West China Hospital, Sichuan University, 37 Guo Xue Xiang St, Chengdu, 610041, Sichuan, China.

Objective: Early diagnosis of intensive care unit-acquired weakness (ICUAW) is crucial for improving the outcomes of critically ill patients. Hence, this study was designed to identify predisposing factors for ICUAW and establish a predictive model for the early diagnosis of ICUAW.

Methods: This prospective observational multicenter study included septic patients from the comprehensive ICUs of West China Hospital of Sichuan University and 10 other hospitals between September and November 2023.

View Article and Find Full Text PDF

Optical techniques, such as functional near-infrared spectroscopy (fNIRS), contain high potential for the development of non-invasive wearable systems for evaluating cerebral vascular condition in aging, due to their portability and ability to monitor real-time changes in cerebral hemodynamics. In this study, thirty-six healthy adults were measured by single channel fNIRS to explore differences between two age groups using machine learning (ML). The subjects, measured during functional magnetic resonance imaging (fMRI) at Oulu University Hospital, were divided into young (age ≤ 32) and elderly (age ≥ 57) groups.

View Article and Find Full Text PDF

Introduction: Non-adherence to tuberculosis (TB) treatment poses a significant challenge to effective TB management globally and is a major contributor to the emergence of multidrug-resistant TB. Although adherence to TB treatment has been widely studied, a comprehensive evaluation of the comparative levels of adherence in high- versus low-TB burden settings remains lacking. The objective of this systematic review and meta-analysis is to assess the levels of adherence to TB treatment in high-TB burden countries compared to low-burden countries.

View Article and Find Full Text PDF

Cerebral perfusion correlates with amyloid deposition in patients with mild cognitive impairment due to Alzheimer's disease.

J Prev Alzheimers Dis

February 2025

Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China, 154 Anshan Road Tianjin 300052, PR China; Department of Neurology, Tianjin Medical University General Hospital Airport Site, Tianjin 300052, PR China. Electronic address:

Background: Changes in cerebral blood flow (CBF) may contribute to the initial stages of the pathophysiological process in patients with Alzheimer's disease (AD). Hypoperfusion has been observed in several brain regions in patients with mild cognitive impairment (MCI). However, the clinical significance of CBF changes in the early stages of AD is currently unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!